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Abstract
Background Patients with Barrett’s esophagus (BE) and esophageal varices present a unique management dilemma. Endoscopic ablation and endoscopic resection are not suitable treatment options due to bleeding risk. Data are limited on successful eradication of BE and esophageal varices utilizing band ligation.
Aims To assess the outcomes of patients with BE and esophageal varices treated with banding.
Methods Retrospective analysis of patients with BE and esophageal varices who were treated with band ligation.
Results A total of eight patients were included in the case series. In all eight cases, BE and esophageal varices were successfully treated with band ligation alone. There were no bleeding, perforation or infectious complications in any patients
undergoing banding for treatment of BE. Four patients had biopsy-proven dysplasia prior to treatment with band ligation.
After band ligation, the 2 of 4 dysplastic cases that had repeat biopsies showed histologic resolution of the dysplasia. All
patients who received banding for BE were followed at least yearly except for one patient lost to follow up. No interval
esophageal cancers were reported in any patients with BE that were banded.
Conclusions Band ligation was used to treat BE pathology in eight patients with esophageal varices. Treatment of dysplasia
through this method yielded negative biopsies both for dysplasia and BE on repeat endoscopy. This case series highlights
the value of utilizing band ligation to address the management dilemma of BE in the context of esophageal varices.
Keywords Barrett’s esophagus · Esophageal varices · Band ligation

Introduction
Barrett’s esophagus (BE) involves metaplasia in which the
normal nonkeratinized stratified squamous epithelium of
the distal esophagus is replaced by nonciliated columnar
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epithelium resembling intestinal epithelium [1]. BE is estimated to affect about 5% of American adults and is the
only recognized risk factor for esophageal adenocarcinoma
[2]. Esophageal varices (EV) classically arise in cirrhotic
patients who develop portal hypertension. Hemorrhage from
EV is the most lethal complication of cirrhosis [3]. Esophageal varices are typically managed with endoscopic variceal
ligation, also known as band ligation, often with the addition
of a beta blocker [4].
Patients with esophageal varices and BE present a unique
management dilemma. Dysplastic BE is typically treated
with radiofrequency ablation (RFA) or endoscopic mucosal
resection (EMR) [5]. However, ablation and resection are
both associated with bleeding and are not suitable treatment options for dysplastic BE with concurrent esophageal
varices. Data are limited on successful eradication of BE and
esophageal varices utilizing band ligation.
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Methods
This is a retrospective case series at a single tertiary care
center from 2014 to 2022 examining the outcomes of
patients with BE and concomitant EV treated with band ligation. ICD 10 codes were used to extract data for patients who

had concurrent diagnoses of BE and EV. Patients who were
treated with band ligation for BE were included. Information
collected included age, sex, cause of portal hypertension,
length of BE, and size of esophageal varices. Outcomes analyzed included number of procedures with banding for BE
pathology, degree of dysplasia before banding, and degree
of dysplasia after banding.

Results

Table 1  Baseline characteristics (N = 8)
Male, n (%)
Age (years), mean ± SD
Cause portal hypertension, n (%)
Alcoholic cirrhosis
Cryptogenic cirrhosis
Portal vein thrombosis
Hepatitis C
Nonalcoholic steatohepatitis
Length BE, n (%)
Short (< 3 cm)
Long (> 3 cm)
Size of Varices, n (%)
Small (grade I and II)
Large (grade III)

6 (75%)
61.3 ± 9.6
4 (50%)
1 (12.5%)
1 (12.5%)
1 (12.5%)
1 (12.5%)
7 (87.5%)
1 (12.5%)
4 (50%)
4 (50%)

A total of eight patients were included in the cohort as
described in Table 1. The mean age was 61.3 ± 9.6 years
and 75% (6/8) were male. Short segment (< 3 cm) BE was
encountered 87.5% (7/8) of patients. An equal number of
patients had large (grade III) and small (grade I and II)
varices. Due to the risk of bleeding, biopsy of the suspected
BE was not performed in 2 cases. In these cases, band ligation was performed based on the gross appearance of BE
with concurrent esophageal varices. Biopsies were obtained
in 6 cases either before and/or after band ligation. All cases
are discussed in further detail below and highlighted in
Table 2. Patients with known high-grade dysplasia (HGD)
were followed monthly for banding until resolution of EV
and BE. All patients who received banding for BE were

Table 2  Case descriptions of BE pathology treated with band ligation
Case Length BE

Size esophageal
varices

No. of treatments with
banding

Pre banding
(endoscopic
appearance)

Post banding
(endoscopic
appearance)

Pre banding
(biopsy)

1

Long (4 cm),
8 mm nodule

Large (grade III)

7

Prague C2-M4,
nodular

Focal HGD, pos- Negative for dysplasia, negative
sible invasive
for BE
adenocarcinoma

2

Short (1 cm)

Small (grade I)

1

Prague C1-M0

3

Short (< 1 cm)

Large (grade III)

2

4

Small (grade II)

4

5

Short (1 cm),
nodular
Short (2 cm)

Large (grade III)

1

6

Short (1 cm)

Small (grade I)

1

7

Short (1 cm)

Small (grade I)

1

0.5 cm flat
salmon-colored
mucosa (Paris
0-IIb)
Prague C0-M1,
nodular
Three 2–3 cm
tongues of
salmon-colored
mucosa
Prague C0-M1,
mild mucosal
irregularity
Prague C0-M1

Slightly irregular
z line, no definite BE seen no
nodularity
Slightly irregular
z line, no definite BE seen
No visible BE

8

Short (1 cm)

Large (grade III)

2

Prague C0-M1
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Post banding
(biopsy)

LGD

Negative for dysplasia, negative
for BE
N/A due to bleed- Negative for dysing concerns
plasia, negative
for BE

No visible BE, no HGD
nodularity
No visible BE
Intestinal metaplasia

N/A due to bleeding concerns
N/A due to bleeding concerns

N/A patient lost
to follow-up

HGD

N/A patient lost to
follow-up

0.3 cm region of
salmon-colored
mucosa
No visible BE

N/A due to bleed- N/A due to bleeding concerns
ing concerns
N/A due to bleed- N/A due to bleeding concerns
ing concerns
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followed at least yearly except for one patient lost to follow
up. There were no bleeding, perforation or infectious complications in any patients undergoing banding for treatment
of BE. No interval esophageal cancers were found in any
patients with BE that were banded.
In case 1, a 73-year-old man with a history of cryptogenic cirrhosis presented with large (grade III) esophageal
varices and long segment BE (4 cm) with an 8 mm nodule
on esophagogastroduodenoscopy (EGD). Biopsies showed
focal high-grade dysplasia (HGD) with possible invasive
adenocarcinoma on the outside endoscopy. Band ligation
was used to treat the EV and the high-grade dysplasia. The
patient was followed monthly for banding for a total of seven
distinct treatments with banding to eradicate the region of
BE. The patient was followed for 2 years after initiation of
treatment with banding and continued annual surveillance is
scheduled. Repeat biopsies have showed complete resolution
of the dysplasia and intestinal metaplasia.
In case 2, a 62-year-old man with a history of hepatitis
C presented with short BE and small esophageal varices on
EGD. Biopsy of the BE showed low grade dysplasia (LGD)
and the region was treated with band ligation. Repeat biopsies after a single treatment with band ligation demonstrated
complete resolution of the region of dysplasia and BE. The
patient was followed yearly with EGD’s for 7 years.
In case 3, a 41-year-old man with a history of alcoholic
cirrhosis was found to have large EV and a short segment
of suspected BE on EGD. Although biopsy of the region
could not be obtained due to an underlying varix, the region
containing the varix and suspected BE was treated with band
ligation on two separate occasions. After treatment, EGD
demonstrated gross resolution of the region and biopsy of
the region indicated no BE. The patient was followed biannually for 1.5 years prior to publication.
In case 4, a 59-year-old woman with a history of portal vein thrombosis presented with small EV and a short
segment of BE reported as high-grade dysplasia on biopsy.
The patient was followed monthly for banding until gross
resolution of the region of BE for a total of 4 separate treatments with banding. The patient had one EGD 3 months
after completion of banding treatment which demonstrated
gross resolution of the region of BE. Repeat biopsy of the
region of HGD was not performed due to the patient’s prior
history of bleeding upon EGD biopsies. Further surveillance
was scheduled but the patient was lost to follow-up after the
initial 3-month follow-up.
In case 5, a 60-year-old woman with a history of nonalcoholic steatohepatitis was found to have large EV and
a short segment of BE confirmed by biopsy. Treatment of
BE with band ligation yielded gross resolution of the BE.
Repeat biopsies of the region were not performed due to the
continued presence of esophageal varices. The patient was
followed at least yearly for 4 years after banding for BE.

In case 6, a 64-year-old man with a history of alcoholic
cirrhosis complicated by bleeding esophageal varices presented with short segment BE and underlying small esophageal varices. The BE was found to be HGD on biopsy.
The patient was treated with band ligation of the region of
BE and underlying varices. Repeat EGD was planned for
3 months after the initial procedure, but unfortunately the
patient was lost to follow-up.
In case 7, a 70-year-old man with alcoholic cirrhosis
was found to have a short segment of esophageal mucosal
changes suspicious for BE extending 1 cm with underlying
small varices. Given the underlying varices, the region was
not biopsied but instead a band was placed around the region
and the underlying varices. At follow-up EGD 1 year later,
the region of salmon-colored mucosa suspicious for BE had
been reduced from 1 to 0.3 cm.
Finally, in case 8 a 61-year-old man with alcoholic cirrhosis presented with a short segment of suspected BE (1 cm)
with underlying and surrounding large varices. The region
containing the varices and suspected BE was banded. On
repeat EGD 1 month later, the region had decreased from
1 to 0.5 cm and was banded again. Follow-up 1 year later
demonstrated normal gastroesophageal junction without
evidence of BE.

Discussion
This case series describes the successful treatment of BE
with and without dysplasia in the setting of esophageal
varices utilizing band ligation. Literature is limited regarding the treatment of BE complicated by esophageal varices.
Ueda et al. reports one case where Barrett’s adenocarcinoma with esophageal varices was successfully managed
with endoscopic submucosal dissection with direct varices
coagulation [6]. Uchima et al. describes a case series of 3
patients with neoplastic BE and EV who were treated with
endoscopic mucosal resection and radiofrequency ablation
[7]. In another case, Raftopoulos et al. reports a single case
of successful eradication of BE and esophageal varices utilizing band ligation [8]. Palmer et al. describes the management of high-grade dysplastic BE and esophageal varices
with band ligation and concludes that band ligation alone
rarely results in complete resolution of dysplastic HGD [9].
In contrast, this case series illustrates four cases of biopsyproven dysplasia (1 LGD and 3 HGD) that were successfully
treated with band ligation alone.
Band ligation has previously been shown to be effective
for short segment BE without dysplasia in non-cirrhotic
patients [10]. Banding for BE is especially useful in cirrhotic patients with bleeding risk who already undergo EGD
surveillance and banding for EV. Band ligation likely works
by strangulation deep enough to slough off the mucosal
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Table 3  Treatment options for BE with concurrent esophageal varices
Treatment method

Benefits

Drawbacks

Endoscopic mucosal resection (EMR) [11]

• Provides tissue specimen for pathology
• High rates of complete eradication of both BE
and dysplasia
• Highly effective at removing BE and dysplasia at both endoscopic and histologic level

• Bleeding; EV are a contraindication
• Other adverse events: perforation (rare) and
stenosis
• Bleeding; EV are a contraindication
• Other adverse events: stricture formation and
pain
• Insufficient to treat nodular disease and cancer
• No pathology specimen to examine
• Bleeding risk still present if biopsy required
• Risk of interval progression to cancer in setting
of dsyplasia
• TIPS increases risk of hepatic encephalopathy

Radiofrequency ablation (RFA) [12–14]

Intensive endoscopic surveillance only [15] • Bleeding risk initially averted

TIPS + another method [16]

Band ligation

• TIPS reduces portal pressure and decreases
risk of variceal bleeding
• After TIPS, RFA or EMR can be pursued
• Treats both BE and EV at same time
• Initial data shows safe and efficacious

layer in addition to strangulating the varices. Some patients
may require several treatments with banding, such as case 1
which required 7 separate banding treatments for focal HGD.
Considering the difficulty of obtaining biopsies to meet diagnostic criteria for BE in these patients, we recommend that
band ligation be considered as an empiric treatment option
for a region of suspected BE with nearby or underlying EV.
This is illustrated in case 3, case 7, and case 8 where biopsies for formal diagnosis could not be made but regions of
suspected BE were successfully treated with band ligation.
Another option to consider in patients with both BE and
EV is a transjugular intrahepatic portosystemic shunt (TIPS)
procedure to relieve portal pressure. After TIPS, treatment
of the BE using more traditional EMR or RFA may be pursued. We have anecdotally previously also managed BE
with HGD and early adenocarcinoma in a background of EV
with TIPS to reduce portal pressure followed by band EMR.
Alternatively, band ligation of EV until eradication could be
performed first. Once varices are eradicated, patients could
undergo EMR or ablation if international normalized ratio
(INR) and platelet counts are in a safe range. A summary
table of treatment options can be seen in Table 3. Ultimately,
band ligation of both EV and BE during the same procedure
provides an efficient and effective treatment in these patients.
The number of procedures is reduced, and the BE can be
managed sooner than if patients undergo variceal banding
until eradication or TIPS followed by EMR or ablation.

13

• Requires two separate procedures to treat BE
pathology
• May require several EGD’s for repeated banding
• Literature is limited on this method
• No pathology specimen is obtained to confirm
eradication of dysplasia/cancer
• Limited size of individual lesion to band of
around 15 mm in a session; risk of not ablating
margin of larger lesions

This case series is limited by the retrospective design
and the small sample sizes of patients with EV and BE.
The difficulty of obtaining biopsies also complicates the
analysis and is a limitation of the study. Even when biopsies can be obtained, conditions at the gastroesophageal
junction such as background inflammation can be confused
with dysplasia especially in the setting of short regions
of suspected BE with limited surface area for biopsies.
In addition, follow up biopsies to confirm eradication of
intestinal metaplasia and dysplasia could only be obtained
in 3 of 8 cases due to associated bleeding risk, which further limits the study. Future considerations for study may
include the potential to utilize banding in the setting of BE
with smaller varices that would otherwise not have been
banded. In conclusion, this case series highlights band
ligation as a valuable treatment option for patients with
BE and EV. BE with underlying EV can be safely managed
with band ligation.
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